Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-malaria compositions and methods

A compositional and antigenic technology, applied in drug combinations, resistance to vector-borne diseases, anti-infectives, etc., can solve problems such as low efficacy, controversial efficacy, and inability to expand the actual number.

Active Publication Date: 2018-05-11
ARTIFICAL CELL TECH INC
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been shown to protect both adults and children from infection, but its effectiveness remains a matter of debate as effectiveness is less than 50%
Sanaria Inc. has proposed the use of dead sporozoites as an effective vaccine, but the production method involves dissecting host mosquito salivary glands, a process that is cumbersome and may not be scalable to practical quantities

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-malaria compositions and methods
  • Anti-malaria compositions and methods
  • Anti-malaria compositions and methods

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0131] Example 1: Exemplary Peptide Design and Synthesis

[0132] The designed peptides are based on the T1BT* multivalent peptide of Plasmodium falciparum CS. The surface adsorption area K 20 (SEQ ID NO: 9) or K 20 Y (SEQ ID NO: 16) was added to the C-terminus to generate a designed polypeptide (DP) for incorporation into LbL particles ( figure 1 ). When Pam3Cys was conjugated to DP, the linker sequence SKKKK was also added. Peptides were synthesized and prepared as C-terminal amides using standard solid-phase peptide chemistry methods. Briefly, fluorenylmethoxycarbonyl (Fmoc) amino acids were double-coupled to Rink MBHA amide resin with a CEM Liberty microwave peptide synthesizer using the manufacturer's synthetic protocol with minor changes in the coupling temperature. After peptide synthesis, the Pam3Cys group was added to the resin by manual coupling of Pam3Cys-OH or automatic coupling of Fmoc-Pam2Cys-OH, followed by Fmoc removal and final capping step with palmitic ...

Embodiment 2

[0147] Example 2: LBL manufacture of vaccine microparticles

[0148] 20cm is equipped for LBL 2 ,500kD(MWCO) mPES filter module from SpectrumLabs (Rancho Dominiguez, CA) Research IIi tangential flow filtration system. Poly-L-glutamic acid sodium salt (PGA) and poly-L-lysine hydrobromide (PLL) were obtained from Sigma-Aldrich, USA (catalog numbers P4636 and P6516, respectively). Using a modified version of the method reported by Volodkin et al., from 0.33MCaCl 2 and 0.33M Na 2 CO 3 Co-precipitated spherical, mesoporous CaCO 3 Core (2 to 5 μm). (D.V. Volodkin et al. Adv. Funct. Mater. 2012, 1). All steps were performed at room temperature.

[0149] TFF unit filled with 20 mL of 3% CaCO 3 (dry weight) microparticle suspension that was kept in constant circulation at 40 mL / min during the treatment. The particles were washed by infiltration with 100 mL of 10 mM HEPES buffer pH 7.4. The permeation valve was closed and a 5.0 mL aliquot of 6.3 mg / mL PLL was added in a si...

Embodiment 3

[0152] Example 3: Immunophenotype induced by immunization with T1BT* microparticles.

[0153] C57BL / 6J mice were immunized with the indicated constructs on days 0, 21 and 42. like figure 2 Sera collected on day 49 were tested in an ELISA against T1B peptide as indicated in . Results show mean ± SD of 10 mice per group. like image 3 Sera were tested at 1:250 and plates were probed with isotype-specific detection antibodies as indicated in . Results show mean ± SD of 10 mice per group. Splenocytes were harvested on day 49 and restimulated with T1B peptide in IFNγ and IL-5 ELISPOT plates as Figure 4 shown in . Data depict mean ± SD of 3 mice per group. nXL = no crosslinking, bXL = base layer crosslinking.

[0154] These results demonstrate that LBL microparticles loaded with designed peptides comprising the T1BT* subunit peptide of the P. falciparum circumsporozoite protein elicit both humoral and cellular immune responses against the contained antigenic epitopes. The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Described herein are multilayer films that include modified polypeptide epitopes from Plasmodium falciparum, specifically a modified T* epitope. The multilayer films are capable of eliciting an immuneresponse in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes the modified T* polypeptide epitope from a Plasmodium protozoan.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application 62 / 219,260, filed September 16, 2015, which is hereby incorporated by reference in its entirety. technical field [0003] The present disclosure relates to compositions and methods for preventing malaria infection, particularly multilayer membrane compositions comprising antigenic epitopes. Background technique [0004] Malaria is one of the most prevalent infections in tropical and subtropical regions of the world. Malaria infection causes severe disease in hundreds of millions of individuals worldwide, resulting in millions of deaths, mainly in developing and emerging countries each year. The widespread occurrence and high incidence of malaria is the result of increased numbers of drug-resistant parasites and insecticide-resistant parasite vectors. Other factors include environmental and climate change, civil unrest, and increased population mobility. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/015A61K39/39A61K9/50A61K9/70A61P33/06A61P37/04
CPCA61K39/39A61K9/146A61K9/1641A61K9/167A61K39/015A61P33/06A61P37/04A61P43/00Y02A50/30C07K7/08
Inventor 詹姆斯·戈勒姆·博伊德托马斯·J·鲍威尔
Owner ARTIFICAL CELL TECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com